ÂÜÀòÂÒÂ×

Marisa Wainszelbaum has a strong background in clinical sciences and translational research. Marisa is currently the Head of Clinical Sciences, Executive Director at Repare Therapeutics, a position they have held since February 2021. Prior to this, they served as the Head of Clinical Sciences, Senior Director at Repare Therapeutics from December 2019 to February 2021.

Before joining Repare Therapeutics, Marisa worked at TESARO, Inc. as the Director of Clinical Science from January 2019 to November 2019, and as the Associate Director of Clinical Science from January 2017 to December 2018.

Earlier in their career, Marisa held various roles at Merrimack, including Translational and Research Team Leader/Associate Director from April 2015 to October 2016, Principal Scientist from May 2014 to April 2015, and Lead Scientist from October 2010 to May 2014. At Merrimack, they contributed to the design and development of multi-arm, biomarker-selected Phase 1 basket studies and conducted pre-clinical investigations on biomarker-driven drug combinations.

Marisa's career began at Washington University School of Medicine, where they worked as a Sr Scientist from 2009 to 2010, Scientist from 2007 to 2009, and Postdoctoral Researcher from 2003 to 2007. During their time at the university, they made significant discoveries in the field of oncology, particularly in relation to the TBC1D3 oncogene and its impact on signaling pathways and endocytosis.

Overall, Marisa Wainszelbaum has a diverse range of experience in the pharmaceutical and biotech industries, with a focus on clinical sciences and translational research.

Marisa Wainszelbaum has a Master's degree in Molecular Biology from the University of Buenos Aires. Marisa also obtained a Ph.D. in Molecular and Cellular Biology from the same university. No specific start or end dates were provided for these educational experiences.